Background Insomnia symptoms are prevalent in older adults and linked to cardiovascular disease (CVD), but the role of ...

Transthyretin amyloidosis (ATTR) is a condition caused by TTR protein misfolding and amyloid deposition, particularly in the ...

> For most of history, Anonymous was a woman. – Virginia Woolf In this well-known quote from her 1929 essay, Virginia Woolf reflects on why women were absent among authors of influential works. While ...

Background Statistical shape atlases have been used in large-cohort studies to investigate relationships between heart shape and risk factors. The generalisability of these relationships between ...

Correspondence to Professor Takeshi Kimura, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; taketaka{at}kuhp.kyoto-u.ac.jp Objectives We ...

Introduction Cardiovascular benefits deriving from physical activity are well known, but it is unclear whether physical activity trajectories in late life are associated with different risks of ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused in older populations due to concerns about bleeding. This study aimed to ...

Background Acute coronary syndrome (ACS) is a global leading cause of morbidity, with residual inflammation contributing to recurrent events. Colchicine has been proposed as an adjunct therapy, but ...

Background Patients with heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation are mostly elderly patients, and persistent atrial fibrillation (PerAF) with multiple ...

Background The 2024 European Society of Cardiology (ESC) Guidelines for hypertension introduced the ‘elevated BP’ (eBP) category (120–139/70–89 mm Hg). Individuals with persistent eBP (130–139/80–89 ...

Correspondence to Dr Arun R Sridhar, Division of Cardiology, Section of Cardiac Electrophysiology, University of Washington Medical Center, Seattle, WA 98195, USA; arun11{at}cardiology.washington.edu ...

Despite significant advances in the treatment of ST elevation myocardial infarction (STEMI), there remains a significant short-term and long-term increased mortality risk. Risk stratification to ...